Latest news for Ambu (OTC:AMBBY) Stock

Ambu A/S is a Denmark based company providing single-use flexible endoscopes and is dedicated to optimizing hospital workflows and improving patient care. The company has created medtech solutions like resuscitators, anaesthesia masks, and electrodes and operates R&D, manufacturing and sales in Europe, North America and the Asia Pacific.

Ambu A/S

LUCYW

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

SONM

TCRT

LUCY

SNTI

MGOL

The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have intensified their oversight of the <a href="http://benzinga.com/cannabis" target="_blank" rel="noreferrer noopener">cannabis</a> industry, issuing another round of warning letters to companies on Tuesday. The businesses are accused of selling products infused with <a href="https://www.benzinga.com/markets/cannabis/24/01/36584043/real-weed-or-a-lab-high-delta-8-and-delta-9-thc-explained" target="_blank" rel="noreferrer noopener">hemp-derived cannabinoids</a>, such as delta-8 THC, in packaging deceptively resembling popular children's snacks.
This move marks the second consecutive year of such actions, signaling a tightening grip on deceptive marketing practices.
<h3 class="wp-block-heading">FTC Targets Deceptive THC Edibles Marketing</h3>
&#8220;Companies that market and sell edible THC products that are easily mistaken for snacks and candy are not only acting illegally, but they are also putting the health of young children at risk,&#8221; Samuel Levine, director of FTC's Bureau of Consumer Protection <a href="https://www.fda.gov/news-events/press-announcements/fda-ftc-continue-joint-effort-protect-consumers-against-companies-illegally-selling-copycat-delta-8" target="_blank" rel="noreferrer noopener">stated</a> in a press release. As Hemp Today <a href="https://hemptoday.net/federal-ban-on-delta-8-other-hemp-derived-intoxicants-could-come-as-early-as-october/" target="_blank" rel="noreferrer noopener">notes</a>, this regulatory spotlight aligns with concerns over delta-8 THC, delta-10 THC, THC-O-acetate, HHC, THCP, and hemp-derived THCA &#8211; substances gaining notoriety for their psychoactive effects yet slipping through legislative cracks.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Today, the FDA and <a href="https://twitter.com/FTC?ref_src=twsrc%5Etfw">@FTC</a> issued warning letters to five companies for illegally selling copycat food products containing Delta-8 THC and introducing them into the marketplace in violation of the Federal Food, Drug, and Cosmetic Act. These warnings serve as part of the FDA and… <a href="https://t.co/71cmdHNk3S">pic.twitter.com/71cmdHNk3S</a>
&mdash; U.S. FDA (@US_FDA) <a href="https://twitter.com/US_FDA/status/1813259864497434910?ref_src=twsrc%5Etfw">July 16, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Real Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/39783607/how-hemp-became-americas-loophole-for-legal-highs" target="_blank" rel="noreferrer noopener">How Hemp Became America&#8217;s Loophole For Legal Highs</a>
<h3 class="wp-block-heading">Congress Debates Hemp Cannabinoid Ban</h3>
Simultaneously, a heated debate is unfolding in Congress about the future legality of consumable hemp-based cannabinoid products. Proposals in recent <a href="https://www.benzinga.com/markets/cannabis/24/07/39698531/gop-led-congressional-committee-passes-bill-to-block-cannabis-rescheduling-deny-state-protection" target="_blank" rel="noreferrer noopener">House-approved appropriations legislation</a> and the forthcoming Farm Bill <a href="https://www.benzinga.com/markets/cannabis/24/05/39006814/house-committee-approval-of-amendment-eliminating-90-of-hemp-dervied-products-could-drive-wedge-" target="_blank" rel="noreferrer noopener">hint at a potential nationwide ban</a>. These legislative actions are compounded by concerns over unregulated cannabis products that make unauthorized health claims.
<h3 class="wp-block-heading">Unknown Compounds From Hemp Conversion Found In Tests</h3>
Amidst this regulatory and legislative flux, a new concern arises from the discovery of numerous unknown compounds in marijuana testing samples, <a href="https://mjbizdaily.com/unknown-compounds-found-in-cannabis-testing-samples-lab-owners-say/" target="_blank" rel="noreferrer noopener">reported</a> by MJBizDaily. These compounds are believed to originate from the process of converting hemp-derived cannabinoids into delta-8 and delta-9 THC. &#8220;These are chemical side reactions,&#8221; explained Susan Audino, a chemist and independent consultant to chemical laboratories.
Josh Swider, CEO of Infinite Chemical Analysis Labs said, &#8220;You'll see 60 unknown compounds in there. Some of them get identified, but all of them are never found. That is telling you that you're now adding other compounds that we never found in cannabis, and now people are smoking it. It's a very common thing going on around the country.
<h3 class="wp-block-heading">FDA Faces CBD Regulation Criticism</h3>
<a href="https://www.benzinga.com/markets/cannabis/23/04/31890021/house-committee-to-investigate-fda-inaction-on-cbd-regulation-gop-chair-warns-about-dangers" target="_blank" rel="noreferrer noopener">The FDA's ongoing failure to regulate CBD</a>, criticized by stakeholders and legislators alike, adds another layer of urgency to these discussions. In a House committee hearing earlier this year, FDA commissioner Robert Califf <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38226873/analyst-reacts-to-fda-commish-comments-medical-and-recreational-cannabis-could-have" target="_blank" rel="noreferrer noopener">addressed criticisms over the agency&#8217;s inaction</a>, suggesting that resolving these issues would require additional congressional support. This legislative backdrop sets the stage for potential sweeping reforms in how hemp-derived products are marketed and regulated.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39610764/intoxicating-hemp-products-face-regulatory-crackdown-across-multiple-states" target="_blank" rel="noreferrer noopener">Intoxicating Hemp Products Face Regulatory Crackdown Across Multiple States</a></li>
</ul>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Cannabis rescheduling seems to be right around the corner. Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a> before prices surge by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.

Cannabis

Government

News

Regulations

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

FDA Accuses Companies Of Marketing Cannabis Products To Children Amid Debate On Hemp Cannabinoids Ban

Kentucky Governor Andy Beshear is urging the Drug Enforcement Administration (DEA) to ease <a href="https://www.benzinga.com/markets/cannabis/24/07/39715542/biden-administration-give-us-more-insight-on-marijuana-rescheduling-decision-congressional-commi">restrictions on marijuana. </a>
In a recent letter addressed to DEA administrator Anne Milgram, Beshear advocated for the reclassification of cannabis from a Schedule I drug, which includes substances like heroin and LSD, to a Schedule III drug, where ketamine and anabolic steroids are listed, Cannabis Business Times <a href="https://www.cannabisbusinesstimes.com/news/dea-reschedule-marijuana-schedule-iii-when-kentucky-governor-andy-beshear-controlled-substances/">reported.</a>
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39277690/dea-vs-biden-fda-health-agency-over-cannabis-rescheduling-whats-up-with-that">DEA Vs. Biden, FDA &amp; Health Agency Over Cannabis Rescheduling: What&#8217;s Up With That?</a>
&#8220;The jury is no longer out on marijuana: It has medical uses and is currently being used for medical purposes,&#8221; Beshear wrote. &#8220;The recognition is overwhelming – and bipartisan. For example, I signed a medical marijuana law that passed with support from Republican legislative supermajorities and a Democratic Governor.&#8221;
<h3 class="wp-block-heading">Medical Marijuana In Kentucky</h3>
Kentucky&#8217;s approach to medical marijuana has evolved significantly under Beshear&#8217;s administration. The governor signed a medical marijuana law that passed with bipartisan support, highlighting the broad acceptance of cannabis&#8217;s medicinal benefits.
Beshear&#8217;s letter comes at a crucial time, with the new medical cannabis program set to go into effect on January 1, 2025. This program aims to provide safe, regulated medical marijuana products to improve the lives of Kentuckians with significant medical conditions.
<h3 class="wp-block-heading">The Case For Rescheduling Cannabis</h3>
The primary distinction between Schedule I and Schedule III drugs lies in their medical value and potential for abuse. Schedule I drugs are deemed to have no medical value and a high potential for abuse, whereas Schedule III drugs have accepted medical uses and a lower potential for abuse. 
According to DEA scheduling practices, marijuana is absurdly classified as more dangerous than fentanyl, oxycodone and methamphetamine. 
Beshear&#8217;s argument is bolstered by data from the Centers for Disease Control and Prevention (CDC), which estimated that 84,181 people died from opioid overdoses in 2022. In contrast, the DEA has not reported any deaths directly attributable to marijuana use.
However, a 2023 study from Florida Atlantic University highlighted that synthetic cannabinoids, which are often more potent and dangerous than natural cannabis, have been linked to 386 deaths between 2014 and 2020.
<h3 class="wp-block-heading">Potential Benefits For Kentuckians</h3>
Beshear emphasized the potential benefits of rescheduling marijuana for Kentuckians, particularly as an alternative to opioids and a means to reduce crime and illicit drug use. &#8220;
As Governor, my job is to move our state forward,&#8221; Beshear stated. &#8220;Rescheduling marijuana to Schedule III is a significant, common-sense step forward for all Kentuckians, especially those with significant medical conditions.&#8221;
<h3 class="wp-block-heading">Looking Ahead</h3>
Kentucky&#8217;s new medical cannabis program is set to launch in 2025, promising to bring relief to thousands of residents suffering from various medical conditions. 
&#8220;We look forward to seeing how safe medical marijuana products will reduce the suffering and improve the lives of tens of thousands of Kentuckians when our program launches,&#8221; Beshear wrote.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/05/39011156/exclusive-we-analyzed-4-000-dea-marijuana-rescheduling-comments-heres-what-americans-really-thin">EXCLUSIVE: We Analyzed 4,000+ DEA Marijuana Rescheduling Comments; Here&#8217;s What Americans Really Think</a></li>
</ul>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39617358/dea-veteran-warns-bidens-plan-to-reclassify-marijuana-will-empower-mexican-chinese-cartels"><a href="https://www.benzinga.com/markets/cannabis/24/06/39537843/applications-open-kentucky-set-to-roll-out-medical-cannabis-in-2025">Applications Are Open: Kentucky Set To Roll Out Medical Cannabis In 2025</a></a></li>
</ul>
Government photo of Andy Beshear

Politics

Kentucky Gov Andy Beshear To DEA: Reschedule Cannabis 'Marijuana Products Will Reduce Suffering'

The facilities, reportedly functioning as fronts for the distribution of cannabis other substances were shut down early Wednesday in what officials describe as one of the largest busts seen by New York Police Dept. (NYPD) and Sheriff&#8217;s Office recently.
The raid comes as part of city-wide clean-up operation, known as <a href="https://www.benzinga.com/markets/cannabis/24/05/38875243/nyc-mayor-adams-on-the-weed-warpath-6m-in-fines-75-closures-4000-illicit-shop-violations-in-firs">Operation Padlock</a>, which has been underway since May of this year.
It is believed that the total illicit cannabis selling shops functioning in <a href="https://www.benzinga.com/topic/new-york-cannabis">NYC</a> amounts to 3600. On ABC7&#8217;s Eyewitness, NYPD chief of patrol John Chell <a href="https://abc7ny.com/post/2-bronx-businesses-raided-nypd-new-york-city/15064172/">said</a> &#8220;we&#8217;ve shut down 18 percent of those stores in six weeks.&#8221;
Authorities raided a location on East Tremont Avenue where the NYPD uncovered 176 pounds of cannabis flower, 0.6 pounds of THC vape products and psilocybin mushroom edibles. The cannabis flower was hidden in various places including in compartments under a couch, covered by ceiling tiles, in filing cabinets, in luggage bags and some in plain view.
Chell said that the bust came after the police responded to a community complaint about a deli that ended up being a cover for an illegal drug distribution center.
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/05/38875243/nyc-mayor-adams-on-the-weed-warpath-6m-in-fines-75-closures-4000-illicit-shop-violations-in-firs"> NYC Mayor Adams On The Weed Warpath: $6M In Fines, 75 Closures, 4000 Illicit Shop Violations In First Week Of &#8216;Operation Padlock To Protect&#8217;</a>
&#8220;Behind the back door it was like the Cesar&#8217;s palace of illegal marijuana, vapes, psychedelic mushrooms&#8230;&#8221;
&#8220;These are all mushroom bars, cereal milk, white chocolate, birthday cake, different flavors,&#8221; explained Lt. Francesca Rosa from the NYC Sheriff&#8217;s Office. &#8220;All of these products are unregulated, unlicensed, this location is unlicensed, they should not have any of this product here.&#8221;
Just blocks away, another establishment on East Tremont Avenue was allegedly functioning as a front for illicit cannabis storage and distribution.
Two workers were arrested during the raid. 
While NYC authorities are moving aggressively to close down unlicensed cannabis shops, the legal cannabis market has been limping along at a disappointedly <a href="https://www.benzinga.com/markets/cannabis/24/07/39777553/is-the-worst-over-for-new-yorks-beleaguered-weed-market-sales-projections-optimistic-though-cann">slow</a> rhythm. As a result, the gap between issued licenses and operational dispensaries continues to <a href="https://www.benzinga.com/markets/cannabis/24/07/39694320/licensed-but-closed-new-yorks-cannabis-dream-faces-bureaucratic-nightmare">widen</a>.
Out of 1,117 licenses issued by the Office of Cannabis Management (OCM), only about 141 dispensaries are operational. This is due mainly to bureaucratic and legal struggles. Additionally, the state&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/04/38230512/its-a-green-day-in-new-york-137-cannabis-licenses-granted-new-jersey-still-in-the-lead">social equity</a> licenses, meant to support those affected by past drug laws and impacted communities, lack sufficient funding and logistical support.
<ul>
<li>Read Next:<a href="https://www.benzinga.com/markets/cannabis/24/06/39322748/unlicensed-cannabis-sellers-fight-back-suing-nyc-for-unconstitutional-crackdowns"> Unlicensed Cannabis Sellers Fight Back, Suing NYC For &#8216;Unconstitutional&#8217; Crackdowns</a></li>
</ul>

Markets

NYC Cops Raid Two Bronx Cannabis Operations, One Was Like 'The Cesar's Palace Of Illegal Marijuana'

The Company is a closed-end, registered fund that will trade on the New York Stock Exchange under the ticker &quot;PDCC.&quot; The offering is expected to close on&nbsp;July 19, 2024, subject to customary closing conditions.
The Company intends to use the proceeds from the capital raised to build a diversified portfolio of senior secured U.S. corporate loans through investments in equity tranches of collateralized loan obligations (CLOs).

IPOs

Pearl Diver Credit Company Reports Pricing Of Its Upsized IPO Of 2.2M Shares At $20 Per Share

Former President Donald Trump previously tried to ban TikTok, but had a reversal of opinion on the Chinese-owned app as a potential <a href="https://www.benzinga.com/markets/equities/24/06/39470496/joe-bidens-tiktok-ban-could-adversely-impact-oracles-revenue-and-profit-tech-giant-warns">U.S. ban is nearing.</a>
What Happened: In a recent interview, Trump said that big technology companies like Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)- owned Facebook and Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)-owned Google and YouTube have become too big and too powerful, something that <a href="https://www.benzinga.com/topic/tiktok">supports having TikTok</a> around for competition.
"I think they're having a huge negative impact on especially young people," Trump said of big technology companies in an interview with <a href="https://www.bloomberg.com/features/2024-trump-interview-transcript/?embedded-checkout=true&amp;sref=TBDibEcD">Bloomberg</a>.
Trump said TikTok is "very powerful."
Asked about a reversal on wanting to ban TikTok, Trump shares his opinion on the need for competition to big technology companies.
"I'm for TikTok because you need competition. If you don't have TikTok, you have Facebook and Instagram, and that's, you know, that's Zuckerberg."
Trump recalled Meta Platforms CEO Mark Zuckerberg banning him from Facebook and Instagram in the interview.
"I went from being No. 1 to having nobody."
Trump had a two-year ban from Facebook and Instagram after the Jan. 6, 2021, attack on the U.S. Capitol over concerns of civil unrest. Trump <a href="https://www.benzinga.com/news/23/02/30848473/trumps-back-on-facebook-and-instagram-for-real">was welcomed back</a> to the platforms in 2023 and recently saw all restrictions lifted.
The former president has also been welcomed back on social media platform X, formerly known as Twitter. While Trump prefers to post on his own social media platform Truth Social, which is owned by Trump Media &amp; Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>), he often uses Facebook to communicate with his followers.
Read Also: <a href="https://www.benzinga.com/news/24/07/39759624/meta-removes-heightened-penalties-on-donald-trumps-accounts-a-day-after-ex-president-threatens-to-pu">Meta Removes &#8216;Heightened Penalties&#8217; On Donald Trump&#8217;s Accounts A Day After Ex-President Threatens To Put Mark Zuckerberg In Jail</a>
Why It's Important: Trump <a href="https://www.benzinga.com/news/24/03/37572294/donald-trump-is-against-tiktok-ban-because-it-would-help-facebook-and-zuckerschmuck-double-their-bus">previously said he</a> is against a ban on TikTok in the U.S. as it could prove advantageous to Facebook and Zuckerberg.
"If you get rid of TikTok, Facebook and Zuckerschmuck will double their business," Trump previously said.
Trump said he doesn't want Facebook to do better as he alleged the company cheated in the 2020 election.
"They are a true Enemy of the People!"
Trump has shown strong opposition to Zuckerberg in recent months. The former president specifically named Zuckerberg as an "election fraudster" who he could<a href="https://www.benzinga.com/news/24/07/39723781/trump-threatens-to-jail-metas-mark-zuckerberg-and-election-fraudsters-if-re-elected-dont-do-it-be-ca"> put in prison</a> if he is elected to the White House.
"They have no shame! All I can say is that if I'm elected President, we will pursue Election Fraudsters at levels never seen before, and they will be sent to prison for long periods of time."
Trump's negativity towards Zuckerberg dates <a href="https://www.benzinga.com/general/social-media/24/04/38152630/if-you-invested-1-000-in-meta-platforms-stock-when-donald-trump-said-facebook-was-always-ant">back several years</a> with the former president accusing Facebook of always being "anti-Trump."
In April, Congress and President Joe Biden signed legislation to force a sale of the U.S. arm of ByteDance-owned TikTok or see the app banned in America.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/04/38368049/trump-reverses-tiktok-ban-stance-accuses-biden-of-favoring-zuckerbergs-meta-doing-it-to-help-faceboo">Trump Reverses TikTok Ban Stance, Accuses Biden Of Favoring Zuckerberg&#8217;s Meta: &#8216;Doing It To Help Facebook Friends Get Richer&#8217;</a></li>
</ul>
Photos: Shutterstock

Social Media

GOOG

GOOGL

Trump 'For TikTok,' Competition To Mark Zuckerberg: 'If You Don't Have TikTok, You Have Facebook And Instagram'

This expansion will add 1.3 million premium seats annually to mainline fleet,&nbsp;providing guests with even more opportunities to upgrade to a premium experience.

Alaska Airlines To Begin Rolling Out Additional First Class And Premium Class Seating Across More Than 200 Of Its Aircraft

Governor Ron DeSantis went there at the<a href="https://www.benzinga.com/topic/rnc"> Republican National Convention</a> (RNC) in Milwaukee on Wednesday: He used his platform to rail against Florida's upcoming vote to <a href="https://www.benzinga.com/markets/cannabis/24/04/38034138/florida-supreme-court-approves-cannabis-legalization-proposal-for-november-election-in-blow-to-d" target="_blank" rel="noreferrer noopener">legalize recreational marijuana</a> telling his comrades that if weed is legalized, people will be able to possess practically limitless amounts of the stuff.    
"It gives you a limitless constitutional right to possess and smoke. I think it's up to like, what, 40 joints, is that the three ounces would be 40? More than that, 80 joints. Something like that," he said. 
In fact, he noted that if the cannabis legalization ballot wins, marijuana rights will surpass the constitutional guarantees of the First and Second Amendments concerning free speech and gun ownership, respectively. And that&#8217;s a statement he&#8217;s already made in the past.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39492507/desantis-says-cannabis-legalization-amendment-will-protect-weed-rights-better-than-1st-2nd-amend">DeSantis Says Cannabis Legalization Amendment Will Protect Weed Rights Better Than 1st, 2nd Amendments Protect Free Speech, Gun Rights</a>
<h2 class="wp-block-heading">Counting Joints</h2>
The language in the legalization initiative, known as Amendment 3, would allow people to possess three ounces of flower or five grams of concentrate, which translates to roughly 27 joints per ounce according to the Governor's math.
"I think you're going to see people, you will be able to bring 20 joints to an elementary school. Is that really going to be good for the state of Florida? I don't think so," DeSantis <a href="https://www.benzinga.com/markets/cannabis/24/06/39311053/desantis-blasts-cannabis-legalization-amendment-says-people-will-be-able-to-bring-20-joints-to-a">said</a> in June.
The governor has issued similar warnings about the dangers of cannabis legalization, but the number of joints he references seems to increase with each tirade, noted Florida Politics, which first <a href="https://floridapolitics.com/archives/684696-ron-desantis-now-says-weed-legalization-would-let-people-have-80-joints-at-a-time/">reported</a> this story from the RNC.
<h2 class="wp-block-heading">Smoky Restaurants</h2>
DeSantis went on to paint a scenario of unchecked public weed consumption, including in private businesses such as restaurants, which he claimed would be difficult to regulate due to the amendment&#8217;s broad language.
"I think you're talking about going downtown somewhere, going to restaurants, all this —you are going to see this. And law enforcement's not going to want to police it at all," he said. "I've had some restaurant guys [say], ‘Well, I won't let them use it in my restaurant,&#8217;" DeSantis continued. "Well, I'm not sure you're going to be able to do that, given how broad it is."
DeSantis also repeated a <a href="https://www.benzinga.com/markets/cannabis/24/06/39346531/desantis-cant-get-past-the-odor-of-weed-to-smell-the-flowers-specifically-430m-annually-in-canna">complaint</a> that seems to have become the bane of his existence: the smell.
"You go to places like Denver. It smells like marijuana," he told the crowd. "It's not been good for quality of life. So that's just the reality. We've seen in in practice in a lot of places. It hasn't delivered what they said it would deliver."
During his speech, DeSantis also linked marijuana legalization with another initiative, Amendment 2, on expanding abortion access. He called on Florida Republicans assembled in Milwaukee to oppose both measures in order to maintain conservative values. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39760907/ron-desantis-floridas-gop-and-hemp-industry-pile-on-to-defeat-marijuana-legalization">Ron DeSantis, Florida&#8217;s GOP And Hemp Industry Pile On To Defeat Marijuana Legalization</a></li>
</ul>
Photo: Benzinga edit with images by&nbsp;<a href="https://en.wikipedia.org/wiki/Ron_DeSantis#/media/File:Ron_DeSantis-crop.jpg" target="_blank" rel="noreferrer noopener">Wikimedia Commons&nbsp;</a>and&nbsp;<a href="https://www.pexels.com/photo/close-up-photo-of-cannabis-plant-7667883/" target="_blank" rel="noreferrer noopener">Kindel Media</a>&nbsp;on Pexels

Events

LASE

Ron DeSantis Blasts Florida's Cannabis Legalization Ballot At RNC: It Would Allow '80 Joints' A Day, Affecting Free Speech And Gun Rights

Earnings

TIRX

TIAN RUIXIANG Holdings Reports FY23 EPS Of $(3.87) Vs $(9.03) Last Year; Revenue Decrease By 8.0% To $1.2M

Wells Fargo analyst Mike Mayo maintains State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) with a Overweight and raises the price target from $91 to $98.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on State Street, Raises Price Target to $98

Capital One Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) shares are trading higher Wednesday. Capital One aims to acquire Discover Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>), which reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/39826835/discover-reports-better-than-expected-q2-results-heres-the-details">second-quarter results after the bell.</a> 
The Details: Discover shares are trading higher after the company reported GAAP earnings of $6.06 per share, beating the estimate of $3.07 per share, and quarterly Net Interest Income (NII) of $3.524 billion.
Additionally, Capital One announced a <a href="https://www.benzinga.com/pressreleases/24/07/b39815404/capital-one-announces-five-year-265-billion-community-benefits-plan-in-connection-with-discover-ac">community benefits plan</a> Wednesday that commits more than $265 billion in lending, investment and philanthropy over five years as part of its <a href="https://www.benzinga.com/m-a/24/02/37204534/capital-one-set-to-acquire-discover-in-landmark-35-3b-deal">proposed acquisition</a> of Discover. 
Capital One said the plan is twice as large as any other community commitment developed in connection with a bank acquisition and demonstrates that the combination of Capital One and Discover will create an opportunity to provide more lending, investment, and services to underserved communities than the institutions would undertake on a stand-alone basis.
Read Next:<a href="https://www.benzinga.com/news/24/07/39796841/lucids-stock-drives-higher-on-2025-model-year-updates-whats-going-on"> Lucid&#8217;s Stock Drives Higher On 2025 Model Year Updates: What&#8217;s Going On?</a>
&#8220;Our commitments to financial inclusion and well-being are core to who we are as a company,&#8221; said Richard Fairbank, CEO of Capital One.&nbsp;
&#8220;That comes to life in our product portfolio, which serves the full spectrum of American consumers, and in the investments we make in our communities. We have a long history of developing innovative ways to serve these core constituencies, and we are committed to ensuring, through this community benefits plan, that our acquisition of Discover builds on our history of positive impact.&#8221;&nbsp;
COF Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Capital One shares are up 3.16% after-hours at $154.20 at the time of publication Wednesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39805320/what-happened-with-canopy-growth-stock-today">What Happened With Canopy Growth Stock Today?</a></li>
</ul>
Image: Shutterstock

After-Hours Center

Movers

Why Capital One Stock Is Climbing

Opko Health Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPK#NASDAQ">OPK</a>) shares are trading higher after-hours Wednesday. The company announced it entered into a $250 million non-dilutive note purchase <a href="https://www.benzinga.com/pressreleases/24/07/g39825467/opko-health-and-healthcare-royalty-enter-into-250-million-note-purchase-agreement-secured-by-ngenl">agreement with HealthCare Royalty (HCRx). </a>
The Details: Opko said the purchase agreement is secured by its profit share payments from Pfizer received pursuant to its license agreement relating to NGENLA, a once-weekly treatment to treat pediatric growth hormone deficiency. 
The $250 million note issued under the Note Purchase Agreement bears interest at the 3-month Secured Overnight Financing Rate (SOFR) subject to a 4% per annum floor, plus 7.5% per annum. The note has a final maturity date of July 2044 with the first four years requiring interest-only payments.
Read Next:<a href="https://www.benzinga.com/news/24/07/39796841/lucids-stock-drives-higher-on-2025-model-year-updates-whats-going-on"> Lucid&#8217;s Stock Drives Higher On 2025 Model Year Updates: What&#8217;s Going On?</a>
&#8220;This transaction with HCRx allows OPKO to retain a significant portion of NGENLA&#8217;s profit share payments in the near term and provides upside over the long term. It also permits OPKO to maintain the full benefit of the $100 million of remaining potential milestone payments from Pfizer,&#8221; said Phillip Frost, M.D., CEO of Opko.
&#8220;Additionally, it provides non-dilutive capital and financial flexibility to advance our research and development activities including our multispecific antibody programs, as well as potentially to repurchase shares of our common stock and convertible notes."
OPK Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Opko Health shares are up 7.07% after-hours at $1.52 at the time of publication Wednesday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39805320/what-happened-with-canopy-growth-stock-today">What Happened With Canopy Growth Stock Today?</a></li>
</ul>
Image: Shutterstock

Health Care

Why Opko Health Shares Are Up After-Hours

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 20 years by 5.96% on an annualized basis producing an average annual return of 14.47%. Currently, Parker Hannifin has a market capitalization of $71.72 billion. 
Buying $100 In PH: If an investor had bought $100 of PH stock 20 years ago, it would be worth $1,497.16 today based on a price of $557.94 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721251823_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In This Stock 20 Years Ago Would Be Worth $1,500 Today

Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) has outperformed the market over the past 15 years by 13.08% on an annualized basis producing an average annual return of 25.38%. Currently, Cintas has a market capitalization of $73.03 billion. 
Buying $100 In CTAS: If an investor had bought $100 of CTAS stock 15 years ago, it would be worth $3,060.29 today based on a price of $719.78 for CTAS at the time of writing.
<h3>Cintas's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721251818_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTAS

Here's How Much $100 Invested In Cintas 15 Years Ago Would Be Worth Today

Scotiabank analyst Tristan Richardson maintains Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) with a Sector Perform and raises the price target from $40 to $43.

Scotiabank Maintains Sector Perform on Williams Companies, Raises Price Target to $43

Ambu A/S 2023 Q4 - Results - Earnings Call Presentation

Ambu A/S 2024 Q1 - Results - Earnings Call Presentation

Ambu A/S (AMBFF) Q1 2024 Earnings Call Transcript

Ambu AS Unsponsored Denmark ADR (AMBBY) stock is up 15.99% over the last 12 months. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives AMBBY stock a score of  0 out of a possible 100. That rank is mainly influenced by a short-term technical score of 0. AMBBY's rank also includes a long-term technical score of 0.  AMBBY

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Ambu

News

Latest news for Ambu (OTC:AMBBY) Stock

Tuesday, March 24, 2020